カテゴリー： QYResearch, 世界

世界の加齢黄斑変性症(AMD)市場

QYResearchが発行した調査報告書（DATA909X03077）
◆英語タイトル：Global Age-related Macular Degeneration Market Professional Survey Report 2019
◆商品コード：DATA909X03077
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、加齢黄斑変性症(AMD)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ウェットAMD、ドライAMDに、用途別には、ドラッグストア、病院、その他にセグメント区分し、加齢黄斑変性症(AMD)の世界市場を分析しました。


・エグゼクティブ・サマリー
・加齢黄斑変性症(AMD)の世界市場概要
・加齢黄斑変性症(AMD)の製造コスト構成分析
・加齢黄斑変性症(AMD)の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・加齢黄斑変性症(AMD)の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・加齢黄斑変性症(AMD)のセグメント分析（種類別）
（ウェットAMD、ドライAMD）
・加齢黄斑変性症(AMD)のセグメント分析（用途別）
（ドラッグストア、病院、その他）
・加齢黄斑変性症(AMD)の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bayer HealthCare、F. Hoffmann-La Roche、Novartis、Regeneron Pharmaceuticals、Alcon、Allergan、Avalanche、Bausch+Lomb、Gilead Sciences、Iconic Therapeutics、Neurotech Pharmaceuticals、Ohr Pharmaceutical、）
・加齢黄斑変性症(AMD)の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Age-related Macular Degeneration market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Age-related Macular Degeneration volume and value at global level, regional level and company level. From a global perspective, this report represents overall Age-related Macular Degeneration market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Age-related Macular Degeneration in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Age-related Macular Degeneration manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Wet AMD
Dry AMD

Segment by Application
Drugstore
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Age-related Macular Degeneration
1.1 Definition of Age-related Macular Degeneration
1.2 Age-related Macular Degeneration Segment by Type
1.2.1 Global Age-related Macular Degeneration Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Age-related Macular Degeneration Segment by Applications
1.3.1 Global Age-related Macular Degeneration Consumption Comparison by Applications (2014-2025)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Age-related Macular Degeneration Overall Market
1.4.1 Global Age-related Macular Degeneration Revenue (2014-2025)
1.4.2 Global Age-related Macular Degeneration Production (2014-2025)
1.4.3 North America Age-related Macular Degeneration Status and Prospect (2014-2025)
1.4.4 Europe Age-related Macular Degeneration Status and Prospect (2014-2025)
1.4.5 China Age-related Macular Degeneration Status and Prospect (2014-2025)
1.4.6 Japan Age-related Macular Degeneration Status and Prospect (2014-2025)
1.4.7 Southeast Asia Age-related Macular Degeneration Status and Prospect (2014-2025)
1.4.8 India Age-related Macular Degeneration Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Age-related Macular Degeneration
2.3 Manufacturing Process Analysis of Age-related Macular Degeneration
2.4 Industry Chain Structure of Age-related Macular Degeneration

3 Development and Manufacturing Plants Analysis of Age-related Macular Degeneration
3.1 Capacity and Commercial Production Date
3.2 Global Age-related Macular Degeneration Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Age-related Macular Degeneration
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Age-related Macular Degeneration Production and Capacity Analysis
4.2 Age-related Macular Degeneration Revenue Analysis
4.3 Age-related Macular Degeneration Price Analysis
4.4 Market Concentration Degree

5 Age-related Macular Degeneration Regional Market Analysis
5.1 Age-related Macular Degeneration Production by Regions
5.1.1 Global Age-related Macular Degeneration Production by Regions
5.1.2 Global Age-related Macular Degeneration Revenue by Regions
5.2 Age-related Macular Degeneration Consumption by Regions
5.3 North America Age-related Macular Degeneration Market Analysis
5.3.1 North America Age-related Macular Degeneration Production
5.3.2 North America Age-related Macular Degeneration Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Age-related Macular Degeneration Import and Export
5.4 Europe Age-related Macular Degeneration Market Analysis
5.4.1 Europe Age-related Macular Degeneration Production
5.4.2 Europe Age-related Macular Degeneration Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Age-related Macular Degeneration Import and Export
5.5 China Age-related Macular Degeneration Market Analysis
5.5.1 China Age-related Macular Degeneration Production
5.5.2 China Age-related Macular Degeneration Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Age-related Macular Degeneration Import and Export
5.6 Japan Age-related Macular Degeneration Market Analysis
5.6.1 Japan Age-related Macular Degeneration Production
5.6.2 Japan Age-related Macular Degeneration Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Age-related Macular Degeneration Import and Export
5.7 Southeast Asia Age-related Macular Degeneration Market Analysis
5.7.1 Southeast Asia Age-related Macular Degeneration Production
5.7.2 Southeast Asia Age-related Macular Degeneration Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Age-related Macular Degeneration Import and Export
5.8 India Age-related Macular Degeneration Market Analysis
5.8.1 India Age-related Macular Degeneration Production
5.8.2 India Age-related Macular Degeneration Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Age-related Macular Degeneration Import and Export

6 Age-related Macular Degeneration Segment Market Analysis (by Type)
6.1 Global Age-related Macular Degeneration Production by Type
6.2 Global Age-related Macular Degeneration Revenue by Type
6.3 Age-related Macular Degeneration Price by Type

7 Age-related Macular Degeneration Segment Market Analysis (by Application)
7.1 Global Age-related Macular Degeneration Consumption by Application
7.2 Global Age-related Macular Degeneration Consumption Market Share by Application (2014-2019)

8 Age-related Macular Degeneration Major Manufacturers Analysis
8.1 Bayer HealthCare
8.1.1 Bayer HealthCare Age-related Macular Degeneration Production Sites and Area Served
8.1.2 Bayer HealthCare Product Introduction, Application and Specification
8.1.3 Bayer HealthCare Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 F. Hoffmann-La Roche
8.2.1 F. Hoffmann-La Roche Age-related Macular Degeneration Production Sites and Area Served
8.2.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Age-related Macular Degeneration Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Regeneron Pharmaceuticals
8.4.1 Regeneron Pharmaceuticals Age-related Macular Degeneration Production Sites and Area Served
8.4.2 Regeneron Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Alcon
8.5.1 Alcon Age-related Macular Degeneration Production Sites and Area Served
8.5.2 Alcon Product Introduction, Application and Specification
8.5.3 Alcon Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allergan
8.6.1 Allergan Age-related Macular Degeneration Production Sites and Area Served
8.6.2 Allergan Product Introduction, Application and Specification
8.6.3 Allergan Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Avalanche
8.7.1 Avalanche Age-related Macular Degeneration Production Sites and Area Served
8.7.2 Avalanche Product Introduction, Application and Specification
8.7.3 Avalanche Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bausch+Lomb
8.8.1 Bausch+Lomb Age-related Macular Degeneration Production Sites and Area Served
8.8.2 Bausch+Lomb Product Introduction, Application and Specification
8.8.3 Bausch+Lomb Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Gilead Sciences
8.9.1 Gilead Sciences Age-related Macular Degeneration Production Sites and Area Served
8.9.2 Gilead Sciences Product Introduction, Application and Specification
8.9.3 Gilead Sciences Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Iconic Therapeutics
8.10.1 Iconic Therapeutics Age-related Macular Degeneration Production Sites and Area Served
8.10.2 Iconic Therapeutics Product Introduction, Application and Specification
8.10.3 Iconic Therapeutics Age-related Macular Degeneration Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Neurotech Pharmaceuticals
8.12 Ohr Pharmaceutical

9 Development Trend of Analysis of Age-related Macular Degeneration Market
9.1 Global Age-related Macular Degeneration Market Trend Analysis
9.1.1 Global Age-related Macular Degeneration Market Size (Volume and Value) Forecast 2019-2025
9.2 Age-related Macular Degeneration Regional Market Trend
9.2.1 North America Age-related Macular Degeneration Forecast 2019-2025
9.2.2 Europe Age-related Macular Degeneration Forecast 2019-2025
9.2.3 China Age-related Macular Degeneration Forecast 2019-2025
9.2.4 Japan Age-related Macular Degeneration Forecast 2019-2025
9.2.5 Southeast Asia Age-related Macular Degeneration Forecast 2019-2025
9.2.6 India Age-related Macular Degeneration Forecast 2019-2025
9.3 Age-related Macular Degeneration Market Trend (Product Type)
9.4 Age-related Macular Degeneration Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Age-related Macular Degeneration Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Age-related Macular Degeneration
Table Global Age-related Macular Degeneration Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Age-related Macular Degeneration Production Market Share by Types in 2018
Figure Wet AMD Product Picture
Figure Dry AMD Product Picture
Table Global Age-related Macular Degeneration Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Age-related Macular Degeneration Consumption Market Share by Applications in 2018
Figure Drugstore
Figure Hospital
Figure Others
Figure Global Age-related Macular Degeneration Revenue (Million USD) (2014-2025)
Figure Global Age-related Macular Degeneration Production (K Units) (2014-2025)
Figure North America Age-related Macular Degeneration Market Size (Million USD) (2014-2025)
Figure Europe Age-related Macular Degeneration Market Size (Million USD) (2014-2025)
Figure China Age-related Macular Degeneration Market Size (Million USD) (2014-2025)
Figure Japan Age-related Macular Degeneration Market Size (Million USD) (2014-2025)
Figure Southeast Asia Age-related Macular Degeneration Market Size (Million USD) (2014-2025)
Figure India Age-related Macular Degeneration Market Size (Million USD) (2014-2025)
Table Age-related Macular Degeneration Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Age-related Macular Degeneration in 2018
Figure Manufacturing Process Analysis of Age-related Macular Degeneration
Figure Industry Chain Structure of Age-related Macular Degeneration
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Age-related Macular Degeneration Manufacturing Plants Distribution
Table Age-related Macular Degeneration Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Age-related Macular Degeneration Capacity (K Units) of Major Manufacturers (2014-2019)
Table Age-related Macular Degeneration Production (K Units) of Major Manufacturers (2014-2019)
Table Age-related Macular Degeneration Production Market Share of Major Manufacturers (2014-2019)
Figure Age-related Macular Degeneration Production Share by Manufacturers in 2018
Table Age-related Macular Degeneration Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Age-related Macular Degeneration Revenue Market Share of Major Manufacturers (2014-2019)
Figure Age-related Macular Degeneration Revenue Share by Manufacturers in 2018
Table Age-related Macular Degeneration Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Age-related Macular Degeneration Production by Regions 2014-2019 (K Units)
Table Global Age-related Macular Degeneration Production Market Share by Regions 2014-2019
Figure Global Age-related Macular Degeneration Production Market Share by Regions in 2018
Table Global Age-related Macular Degeneration Revenue by Regions 2014-2019 (Million USD)
Table Global Age-related Macular Degeneration Revenue Market Share by Regions 2014-2019
Figure Global Age-related Macular Degeneration Revenue Market Share by Regions in 2018
Table Global Age-related Macular Degeneration Consumption by Regions 2014-2019 (K Units)
Table Global Age-related Macular Degeneration Consumption Market Share by Regions 2014-2019
Figure North America Age-related Macular Degeneration Production Growth Rate 2014-2019 (K Units)
Figure North America Age-related Macular Degeneration Revenue Growth Rate 2014-2019 (Million USD)
Table North America Age-related Macular Degeneration Production, Consumption Import and Export (K Units)
Figure Europe Age-related Macular Degeneration Production Growth Rate 2014-2019 (K Units)
Figure Europe Age-related Macular Degeneration Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Age-related Macular Degeneration Production, Consumption Import and Export (K Units)
Figure China Age-related Macular Degeneration Production Growth Rate 2014-2019 (K Units)
Figure China Age-related Macular Degeneration Revenue Growth Rate 2014-2019 (Million USD)
Table China Age-related Macular Degeneration Production, Consumption Import and Export (K Units)
Figure Japan Age-related Macular Degeneration Production Growth Rate 2014-2019 (K Units)
Figure Japan Age-related Macular Degeneration Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Age-related Macular Degeneration Production, Consumption Import and Export (K Units)
Figure Southeast Asia Age-related Macular Degeneration Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Age-related Macular Degeneration Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Age-related Macular Degeneration Production, Consumption Import and Export (K Units)
Figure India Age-related Macular Degeneration Production Growth Rate 2014-2019 (K Units)
Figure India Age-related Macular Degeneration Revenue Growth Rate 2014-2019 (Million USD)
Table India Age-related Macular Degeneration Production, Consumption Import and Export (K Units)
Figure Global Consumption Age-related Macular Degeneration Market Share by Application (2014-2019)
Figure Global Value (Consumption) Age-related Macular Degeneration Market Share by Application (2014-2019)
Table Bayer HealthCare Age-related Macular Degeneration Production Sites and Area Served
Table Bayer HealthCare Age-related Macular Degeneration Product Introduction, Application and Specification
Table Bayer HealthCare Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer HealthCare Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Bayer HealthCare Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Bayer HealthCare Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Bayer HealthCare Age-related Macular Degeneration Main Business and Markets Served
Table F. Hoffmann-La Roche Age-related Macular Degeneration Production Sites and Area Served
Table F. Hoffmann-La Roche Age-related Macular Degeneration Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Age-related Macular Degeneration Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Age-related Macular Degeneration Main Business and Markets Served
Table Novartis Age-related Macular Degeneration Production Sites and Area Served
Table Novartis Age-related Macular Degeneration Product Introduction, Application and Specification
Table Novartis Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Novartis Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Novartis Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Novartis Age-related Macular Degeneration Main Business and Markets Served
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Production Sites and Area Served
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Product Introduction, Application and Specification
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Main Business and Markets Served
Table Alcon Age-related Macular Degeneration Production Sites and Area Served
Table Alcon Age-related Macular Degeneration Product Introduction, Application and Specification
Table Alcon Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Alcon Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Alcon Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Alcon Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Alcon Age-related Macular Degeneration Main Business and Markets Served
Table Allergan Age-related Macular Degeneration Production Sites and Area Served
Table Allergan Age-related Macular Degeneration Product Introduction, Application and Specification
Table Allergan Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Allergan Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Allergan Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Allergan Age-related Macular Degeneration Main Business and Markets Served
Table Avalanche Age-related Macular Degeneration Production Sites and Area Served
Table Avalanche Age-related Macular Degeneration Product Introduction, Application and Specification
Table Avalanche Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Avalanche Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Avalanche Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Avalanche Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Avalanche Age-related Macular Degeneration Main Business and Markets Served
Table Bausch+Lomb Age-related Macular Degeneration Production Sites and Area Served
Table Bausch+Lomb Age-related Macular Degeneration Product Introduction, Application and Specification
Table Bausch+Lomb Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bausch+Lomb Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Bausch+Lomb Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Bausch+Lomb Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Bausch+Lomb Age-related Macular Degeneration Main Business and Markets Served
Table Gilead Sciences Age-related Macular Degeneration Production Sites and Area Served
Table Gilead Sciences Age-related Macular Degeneration Product Introduction, Application and Specification
Table Gilead Sciences Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Sciences Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Gilead Sciences Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Gilead Sciences Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Gilead Sciences Age-related Macular Degeneration Main Business and Markets Served
Table Iconic Therapeutics Age-related Macular Degeneration Production Sites and Area Served
Table Iconic Therapeutics Age-related Macular Degeneration Product Introduction, Application and Specification
Table Iconic Therapeutics Age-related Macular Degeneration Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Iconic Therapeutics Age-related Macular Degeneration Production Growth Rate (2014-2019)
Table Iconic Therapeutics Age-related Macular Degeneration Production Market Share (2014-2019)
Figure Iconic Therapeutics Age-related Macular Degeneration Revenue Market Share (2014-2019)
Table Iconic Therapeutics Age-related Macular Degeneration Main Business and Markets Served
Table Neurotech Pharmaceuticals Age-related Macular Degeneration Production Sites and Area Served
Table Ohr Pharmaceutical Age-related Macular Degeneration Production Sites and Area Served
Figure Global Age-related Macular Degeneration Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Age-related Macular Degeneration Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Age-related Macular Degeneration Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Age-related Macular Degeneration Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Age-related Macular Degeneration Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Age-related Macular Degeneration Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Age-related Macular Degeneration Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Age-related Macular Degeneration Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Age-related Macular Degeneration Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Age-related Macular Degeneration Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Age-related Macular Degeneration Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Age-related Macular Degeneration Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Age-related Macular Degeneration Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Age-related Macular Degeneration Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Age-related Macular Degeneration Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Age-related Macular Degeneration by Type (2019-2025)
Table Global Consumption (K Units) of Age-related Macular Degeneration by Application (2019-2025)
Table Age-related Macular Degeneration Distributors List
Table Age-related Macular Degeneration Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer HealthCare、F. Hoffmann-La Roche、Novartis、Regeneron Pharmaceuticals、Alcon、Allergan、Avalanche、Bausch+Lomb、Gilead Sciences、Iconic Therapeutics、Neurotech Pharmaceuticals、Ohr Pharmaceutical、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の加齢黄斑変性症(AMD)市場(Global Age-related Macular Degeneration Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測
  • 世界のサバ産業：成長傾向・競合分析
  • 世界のリチウム金属二次電池産業：成長傾向・競合分析
  • 世界のオーディオビジュアルケーブル産業：成長傾向・競合分析
  • 世界のトラディショナル・バーチェア市場
  • 世界の信号トランス市場
  • 世界のポータブル加湿器市場
  • 世界のナノろ過膜市場
  • 世界のN,N-ジエチルエタノールアミン市場
  • 世界の等温核酸増幅技術（INAAT）市場
  • 世界のガラス瓶型市場
  • 世界のDPCセラミック基板市場
  • 世界の自動車用炭素繊維市場
  • 世界のアルミ鋳物市場
  • 世界の合金鋳鉄金型市場